metricas
Vacunas (English Edition)
Vacunas (English Edition)
ISSN: 2445-1460

Official journal of the Asociación Española de Vacunología.

Vacunas publishes research articles related to the field of vaccine-preventable diseases in humans and those with zoonotic potential in animals. It places special emphasis on aspects associated with planning and evaluation, including the epidemiology of vaccine-preventable diseases, the development of vaccination programs, and the evaluation of the efficacy, effectiveness, and efficiency of vaccinations. It accepts articles in both Spanish and English.

The areas of interest of the journal are as follows:

    - Vaccine development and evaluation

    - Epidemiology of vaccine-preventable diseases

    - Regulatory affairs and commercial utilization and historical background of vaccines

    - Vaccine technology, vectors, adjuvants, and immunomodulators

    - Public health policies and vaccination programs

    - Vaccine immunology and mechanisms of action

    - Immunological mechanisms

    - Vaccine safety, efficacy, and effectiveness

    - Vaccine hesitancy and acceptance

    - Vaccines for chronic conditions, autoimmune diseases, allergies, and non-communicable diseases

    - Veterinary vaccines for animal health from a One Health perspective

See more Open Access Option
Indexed in:

Scopus, EMBASE/Excerpta Médica e IBECS

See more
Follow us
Contact
Subscribe
Alert
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2024
3.7
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2024
0.386
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2024
0.384
View more metrics
Hide
Issue
Cover Vol. 27. Issue 3. Vol. 27. Issue 3.
(July - September 2026)
Editorial
Originals
Computational analysis of the monkeypox spread on median-joining and maximum parsimony networks
A. Ahmad, S. Majaz, B. Mukhtiar, S. ul Ghafoor, I. Naeem, H. Ur Rahman
Vacunas. 2026;27:
Special articles
CARABELA-IP exploratory focus group: Understanding vaccination challenges in immunocompromised patients - a patient-centered approach
J. Pérez, M.G. de la Vega, G. Montes, I. Mediavilla, J.F. Soto, L. Escudero, M.E. González, V. Nartallo, ... on behalf of CARABELA-IP Scientific Committee
Vacunas. 2026;27:
Review articles
H5N1 influenza: Pathogenesis, clinical manifestations, and management approaches: A state-of-the-art review
M.G. Mastoi, R. Rani, F.N.U. Deepa, M.W. Afzal, A. perveen, J. Malik
Vacunas. 2026;27:
Special article
Special Article
Letter to the editor
Exploring the potential of mRNA vaccines in oncology: A new Frontier with limited regulations
R.G. Gopalsamy, K. Athesh, M. dos Santos Barreto, L.A. da Mota Santana, L.P. Borges
Vacunas. 2026;27:
Rabies vaccination does not always ensure protective immunity: implications for elimination strategies
J. Gao, P. Wang, S. Dong, Q. Shang, J. Zhang, M. Zhang, M.M. Hasan, Md. F. Kulyar
Vacunas. 2026;27:
asdasdasd